These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9681236)

  • 1. Severe bactrim-induced neutropenia with reversal of CD4+/CD8+ lymphocyte ratio: response to recombinant human granulocyte-colony stimulating factor (R-metHUG-CSF).
    Krishnan K; Krishnaswamy G
    Clin Lab Haematol; 1998 Jun; 20(3):187-8. PubMed ID: 9681236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myeloid progenitor cell growth characteristics and effect of G-CSF in a patient with congenital cyclic neutropenia.
    Tsunogake S; Nagashima S; Maekawa R; Takano N; Kajitani H; Saito K; Enokihara H; Furusawa S; Shishido H
    Int J Hematol; 1991 Jun; 54(3):251-6. PubMed ID: 1720982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the potency of glycosylated and nonglycosylated recombinant human granulocyte colony-stimulating factors in neutropenic and nonneutropenic CD rats.
    Nohynek GJ; Plard JP; Wells MY; Zerial A; Roquet F
    Cancer Chemother Pharmacol; 1997; 39(3):259-66. PubMed ID: 8996530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Granulocyte colony stimulating factor significantly influences neutrophil recovery and duration of hospitalisation in bone marrow transplantation.
    Teoh GK; Tan PH; Goh YT
    Ann Acad Med Singap; 1994 Nov; 23(6):823-7. PubMed ID: 7537949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of a randomised, controlled, multicentre study of recombinant human granulocyte colony-stimulating factor (filgrastim) in patients with Hodgkin's disease and non-Hodgkin's lymphoma undergoing autologous bone marrow transplantation.
    Schmitz N; Dreger P; Zander AR; Ehninger G; Wandt H; Fauser AA; Kolb HJ; Zumsprekel A; Martin A; Hecht T
    Bone Marrow Transplant; 1995 Feb; 15(2):261-6. PubMed ID: 7539668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term safety of treatment with recombinant human granulocyte colony-stimulating factor (r-metHuG-CSF) in patients with severe congenital neutropenias.
    Bonilla MA; Dale D; Zeidler C; Last L; Reiter A; Ruggeiro M; Davis M; Koci B; Hammond W; Gillio A; Welte K
    Br J Haematol; 1994 Dec; 88(4):723-30. PubMed ID: 7529539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant human granulocyte-colony-stimulating factor in the treatment of patients with neutropenia.
    Boxer LA; Hutchinson R; Emerson S
    Clin Immunol Immunopathol; 1992 Jan; 62(1 Pt 2):S39-46. PubMed ID: 1370264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased levels of myeloid progenitor cells associated with long-term administration of recombinant human granulocyte colony-stimulating factor in patients with autoimmune neutropenia.
    Taniguchi S; Shibuya T; Harada M; Niho Y
    Br J Haematol; 1993 Mar; 83(3):384-7. PubMed ID: 7683484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biopharmaceutical drug development: Filgrastim (r-metHuG-CSF) use in patients with HIV infection.
    Foote M; Welch W
    J Hematother Stem Cell Res; 1999; 8 Suppl 1():S3-8. PubMed ID: 10596029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multilineage response in aplastic anemia patients following long-term administration of filgrastim (recombinant human granulocyte colony stimulating factor).
    Sonoda Y; Ohno Y; Fujii H; Takahashi T; Nakayama S; Haruyama H; Nasu K; Shimazaki C; Hara H; Kanamaru A
    Stem Cells; 1993 Nov; 11(6):543-54. PubMed ID: 7509223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia.
    Dale DC; Bonilla MA; Davis MW; Nakanishi AM; Hammond WP; Kurtzberg J; Wang W; Jakubowski A; Winton E; Lalezari P
    Blood; 1993 May; 81(10):2496-502. PubMed ID: 8490166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of chronic neutropenia associated with large granular lymphocytosis with cyclosporine A and filgrastim.
    Jakubowski A; Winton EF; Gencarelli A; Gabrilove J
    Am J Hematol; 1995 Dec; 50(4):288-91. PubMed ID: 7485104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a nonsense mutation in the granulocyte-colony-stimulating factor receptor in severe congenital neutropenia.
    Dong F; Hoefsloot LH; Schelen AM; Broeders CA; Meijer Y; Veerman AJ; Touw IP; Löwenberg B
    Proc Natl Acad Sci U S A; 1994 May; 91(10):4480-4. PubMed ID: 7514305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of chronic severe neutropenia with weekly recombinant granulocyte-colony stimulating factor.
    Fine KD; Byrd TD; Stone MJ
    Br J Haematol; 1997 Apr; 97(1):175-8. PubMed ID: 9136962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human recombinant granulocyte colony-stimulating factor for the treatment of autoimmune neutropenia.
    Takahashi K; Taniguchi S; Akashi K; Fujimoto K; Sibuya T; Ishibashi H; Harada M; Niho Y
    Acta Haematol; 1991; 86(2):95-8. PubMed ID: 1719726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Childhood polyclonal T cell lymphocytosis with neutropenia: effects of antilymphocyte globulin and granulocyte colony stimulating factor in vitro and in vivo.
    Laurie AS; Gibson FM; Josten KM; Talbot PJ; Rutherford TR; Lilleyman JS; Gordon-Smith EC
    Br J Haematol; 1992 Apr; 80(4):446-51. PubMed ID: 1374632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk and benefit of treatment of severe chronic neutropenia with granulocyte colony-stimulating factor.
    Cottle TE; Fier CJ; Donadieu J; Kinsey SE
    Semin Hematol; 2002 Apr; 39(2):134-40. PubMed ID: 11957197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erysipelas in neutropenia of unknown origin, successfully treated with r-metHuG-CSF (filgrastim).
    Müller-Lühr M; Breyer N; Martin A; Haacke H
    Ann Hematol; 1994 Aug; 69(2):97-8. PubMed ID: 7521672
    [No Abstract]   [Full Text] [Related]  

  • 19. The protein tyrosine kinase JAK2 is activated in neutrophils from patients with severe congenital neutropenia.
    Rauprich P; Kasper B; Tidow N; Welte K
    Blood; 1995 Dec; 86(12):4500-5. PubMed ID: 8541539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of granulocyte colony-stimulating factor (G-CSF) on neutropenia in zidovudine-treated patients with AIDS and ARC: a preliminary report.
    Garavelli PL
    Haematologica; 1992; 77(3):293-4. PubMed ID: 1385275
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.